[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Intravenous Immunoglobulin (IVIg) Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

November 2017 | 123 pages | ID: CABB236B80AEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.


Scope of the Report:

This report focuses on the Intravenous Immunoglobulin (IVIg) in China market, to split the market based on manufacturers, Regions (Province), type and application.

Market Segment by Manufacturers, this report covers
  • Baxter
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang
Market Segment by Regions (Province), covering
  • South China
  • Southwest China
  • East China
  • Northeast China
  • North China
  • Market Segment by Type, covers
    • IVIg Liquid
    • IVIg Powder
    Market Segment by Applications, can be divided into
    • Immunodeficiency
    • Autoimmune Disease
    • Acute Infection
    There are 18 Chapters to deeply display the China Intravenous Immunoglobulin (IVIg) market.

    Chapter 1, to describe Intravenous Immunoglobulin (IVIg) Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force;

    Chapter 2, to analyze the manufacturers of Intravenous Immunoglobulin (IVIg), with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

    Chapter 4,to show the China market by Regions (Province),covering South China,East China,Southwest China,North China,Northeast China,Northwest China and Central China,with sales, price,revenue and market share of Intravenous Immunoglobulin (IVIg),for each region,from 2012 to 2017;

    Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

    Chapter 7,8,9,10,11,12 and 13 to analyze the key Province by Type and Application,covering South China,East China,Southwest China,North China,Northwest China,Central China and Northeast China,with sales,revenue and market share by types and applications;

    Chapter 14, Intravenous Immunoglobulin (IVIg) market forecast, by Regions (Province), type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

    Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

    Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

    Chapter 17, to describe sales channel, distributors, traders, dealers etc.

    Chapter 18, to describe Intravenous Immunoglobulin (IVIg) Appendix, methodology and data source
    1 MARKET OVERVIEW

    1.1 Intravenous Immunoglobulin (IVIg) Introduction
    1.2 Market Analysis by Type
      1.2.1 IVIg Liquid
      1.2.2 IVIg Powder
    1.3 Market Analysis by Applications
      1.3.1 Immunodeficiency
      1.3.2 Autoimmune Disease
      1.3.3 Acute Infection
    1.4 Market Analysis by Regions (Province)
      1.4.1 South China Status and Prospect (2012-2022)
      1.4.2 Southwest China Status and Prospect (2012-2022)
      1.4.3 East China Status and Prospect (2012-2022)
      1.4.4 Northeast China Status and Prospect (2012-2022)
      1.4.5 North China Status and Prospect (2012-2022)
      1.4.6 Central China Status and Prospect (2012-2022)
      1.4.7 Northwest China Status and Prospect (2012-2022)
    1.5 Market Dynamics
      1.5.1 Market Opportunities
      1.5.2 Market Risk
      1.5.3 Market Driving Force

    2 MANUFACTURERS PROFILES

    2.1 Baxter
      2.1.1 Profile
      2.1.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.1.2.1 Type
        2.1.2.2 Type
      2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.1.4 Business Overview
      2.1.5 Baxter News
    2.2 Grifols
      2.2.1 Profile
      2.2.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.2.2.1 Type
        2.2.2.2 Type
      2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.2.4 Business Overview
      2.2.5 Grifols News
    2.3 CSL
      2.3.1 Profile
      2.3.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.3.2.1 Type
        2.3.2.2 Type
      2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.3.4 Business Overview
      2.3.5 CSL News
    2.4 Octapharma
      2.4.1 Profile
      2.4.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.4.2.1 Type
        2.4.2.2 Type
      2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.4.4 Business Overview
      2.4.5 Octapharma News
    2.5 Biotest
      2.5.1 Profile
      2.5.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.5.2.1 Type
        2.5.2.2 Type
      2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.5.4 Business Overview
      2.5.5 Biotest News
    2.6 Kedrion
      2.6.1 Profile
      2.6.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.6.2.1 Type
        2.6.2.2 Type
      2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.6.4 Business Overview
      2.6.5 Kedrion News
    2.7 Hualan Bio
      2.7.1 Profile
      2.7.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.7.2.1 Type
        2.7.2.2 Type
      2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.7.4 Business Overview
      2.7.5 Hualan Bio News
    2.8 CNBG
      2.8.1 Profile
      2.8.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.8.2.1 Type
        2.8.2.2 Type
      2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.8.4 Business Overview
      2.8.5 CNBG News
    2.9 Shanghai RAAS
      2.9.1 Profile
      2.9.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.9.2.1 Type
        2.9.2.2 Type
      2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.9.4 Business Overview
      2.9.5 Shanghai RAAS News
    2.10 CBPO
      2.10.1 Profile
      2.10.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.10.2.1 Type
        2.10.2.2 Type
      2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.10.4 Business Overview
      2.10.5 CBPO News
    2.11 LFB Group
      2.11.1 Profile
      2.11.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.11.2.1 Type
        2.11.2.2 Type
      2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.11.4 Business Overview
      2.11.5 LFB Group News
    2.12 BPL
      2.12.1 Profile
      2.12.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.12.2.1 Type
        2.12.2.2 Type
      2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.12.4 Business Overview
      2.12.5 BPL News
    2.13 Sichuan Yuanda Shuyang
      2.13.1 Profile
      2.13.2 Intravenous Immunoglobulin (IVIg) Type and Applications
        2.13.2.1 Type
        2.13.2.2 Type
      2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.13.4 Business Overview
      2.13.5 Sichuan Yuanda Shuyang News

    3 CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET COMPETITION, BY MANUFACTURER

    3.1 China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer (2016-2017)
    3.2 China Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer (2016-2017)
    3.3 China Intravenous Immunoglobulin (IVIg) Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
      3.4.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share
      3.4.2 Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share
    3.5 Market Competition Trend

    4 CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET ANALYSIS BY REGIONS (PROVINCE)

    4.1 China Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (Province)
    4.2 China Intravenous Immunoglobulin (IVIg) Sales by Regions (Province) (2012-2017)
    4.3 China Intravenous Immunoglobulin (IVIg) Revenue (Value) by Regions (Province) (2012-2017)

    5 CHINA MARKET SEGMENTATION INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY TYPE

    5.1 China Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2012-2017)
      5.1.1 China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2012-2017)
      5.1.2 China Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
    5.2 IVIg Liquid Sales Growth and Price
      5.2.1 China IVIg Liquid Sales Growth (2012-2017)
      5.2.2 China IVIg Liquid Price (2012-2017)
    5.3 IVIg Powder Sales Growth and Price
      5.3.1 China IVIg Powder Sales Growth (2012-2017)
      5.3.2 China IVIg Powder Price (2012-2017)

    6 CHINA MARKET SEGMENTATION INTRAVENOUS IMMUNOGLOBULIN (IVIG) BY APPLICATION

    6.1 China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2012-2017)
    6.2 Immunodeficiency Sales Growth (2012-2017)
    6.3 Autoimmune Disease Sales Growth (2012-2017)
    6.4 Acute Infection Sales Growth (2012-2017)

    7 SOUTH CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    7.1 South China Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
    7.2 South China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
    7.3 South China Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

    8 EAST CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    8.1 East China Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
    8.2 East China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
    8.3 East China Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

    9 SOUTHWEST CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    9.1 Southwest China Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
    9.2 Southwest China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
    9.3 Southwest China Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

    10 NORTHEAST CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    10.1 Northeast China Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
    10.2 Northeast China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
    10.3 Northeast China Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

    11 NORTH CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    11.1 North China Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
    11.2 North China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
    11.3 North China Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

    12 CENTRAL CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    12.1 Central China Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
    12.2 Central China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
    12.3 Central China Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

    13 NORTHWEST CHINA INTRAVENOUS IMMUNOGLOBULIN (IVIG) SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    13.1 Northwest China Intravenous Immunoglobulin (IVIg) Revenue, Sales and Growth Rate (2012-2017)
    13.2 Northwest China Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type
    13.3 Northwest China Intravenous Immunoglobulin (IVIg) Sales by Application (2012-2017)

    14 INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET FORECAST (2017-2022)

    14.1 China Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2017-2022)
    14.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (Province) (2017-2022)
    14.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2017-2022)
    14.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2017-2022)

    15 INTRAVENOUS IMMUNOGLOBULIN (IVIG) MANUFACTURING COST ANALYSIS

    15.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
      15.1.1 Key Raw Materials
      15.1.2 Price Trend of Key Raw Materials
      15.1.3 Key Suppliers of Raw Materials
      15.1.4 Market Concentration Rate of Raw Materials
    15.2 Proportion of Manufacturing Cost Structure
      15.2.1 Raw Materials
      15.2.2 Labor Cost
      15.2.3 Manufacturing Expenses
    15.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)

    16 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

    16.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
    16.2 Upstream Raw Materials Sourcing
    16.3 Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
    16.4 Downstream Buyers

    17 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

    17.1 Sales Channel
      17.1.1 Direct Marketing
      17.1.2 Indirect Marketing
      17.1.3 Marketing Channel Future Trend
    17.2 Distributors, Traders and Dealers

    18 RESEARCH FINDINGS AND CONCLUSION

    19 APPENDIX

    19.1 Methodology
    19.2 Analyst Introduction
    19.3 Data Source
    LIST OF TABLES AND FIGURES

    Figure Intravenous Immunoglobulin (IVIg) Picture
    Table Product Specifications of Intravenous Immunoglobulin (IVIg)
    Figure China Sales Market Share of Intravenous Immunoglobulin (IVIg) by Types in


    More Publications